About 40% of at-risk patients with COPD did not receive maintenance therapy despite having frequent or severe exacerbations.

The maintenance inhalers available for obstructive lung disease are long-acting beta-agonists (LABAs), long-acting muscarinic antagonists (LAMAs), and inhaled corticosteroids (ICSs). We use all three ...

Please provide your email address to receive an email when new articles are posted on . This analysis spanned from 2016 to 2022. Nearly 50% of patients were initially prescribed LABA/inhaled ...

Early identification and treatment of patients with COPD at risk of exacerbation are crucial for better outcomes. Single-inhaler triple therapy (SITT) users showed improved exacerbation rates and ...

David Mannino is co-founder and chief medical officer of the COPD Foundation. He's an internal medicine doctor with a specialty in pulmonary, critical care, and sleep medicine at University of ...

Many patients with chronic obstructive pulmonary disease (COPD) have uncontrolled disease despite appropriate use of triple therapy. These patients often exhibit type 2 inflammation, as indicated by ...

AJMC®: How is COPD definitively diagnosed in clinical practice, and how does this disease create a clinical burden on patients and caregivers? Dr Rali: COPD diagnosis requires both clinical context ...

When my dad was diagnosed with chronic obstructive pulmonary disease (COPD) in 2004, I did what many caregivers do: I started ...